262 related articles for article (PubMed ID: 8992641)
1. [Downstaging of esophageal carcinoma after preoperative radio- and chemotherapy].
Staar S
Strahlenther Onkol; 1996 Dec; 172(12):693-5. PubMed ID: 8992641
[No Abstract] [Full Text] [Related]
2. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
5. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Elsaleh H; Farrell JJ; Crane CH
J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
[No Abstract] [Full Text] [Related]
6. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
7. Therapy for esophageal cancer.
Heath EI; Forastiere AA
Cancer Treat Res; 2001; 105():387-98. PubMed ID: 11224996
[No Abstract] [Full Text] [Related]
8. Neoadjuvant treatment of oesophageal adenocarcinoma.
Robb WB; Naughton P; Walsh TN
Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
[TBL] [Abstract][Full Text] [Related]
9. An appropriate esophagectomy for esophageal cancer: a lack of evidence and a growing disparity between Western and Eastern standards.
Nishimaki T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):231-3. PubMed ID: 16977290
[No Abstract] [Full Text] [Related]
10. Palliative chemotherapy does not improve survival in metastatic esophageal cancer.
Adenis A; Penel N; Horn S; Dominguez S; Vanhuyse M; Mirabel X
Oncology; 2010; 79(1-2):46-54. PubMed ID: 21071989
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
Rice DC; Correa AM; Vaporciyan AA; Sodhi N; Smythe WR; Swisher SG; Walsh GL; Putnam JB; Komaki R; Ajani JA; Roth JA
Ann Thorac Surg; 2005 Feb; 79(2):391-7; discussionn 391-7. PubMed ID: 15680801
[TBL] [Abstract][Full Text] [Related]
12. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
13. [Laparoscopic esophagectomy in palliative treatment of advanced esophageal carcinoma after neoadjuvant radiochemotherapy].
Del Genio A
G Chir; 2005 Apr; 26(4):121-9. PubMed ID: 16035246
[No Abstract] [Full Text] [Related]
14. Closing the loop around esophagectomy after neoadjuvant therapy.
Demeester SR
Ann Surg; 2009 Sep; 250(3):500; author reply 500. PubMed ID: 19730188
[No Abstract] [Full Text] [Related]
15. [Squamous cell cancer of the esophagus. Treatment concept at the surgical clinic of the Munich Technical University].
Siewert JR; Bartels H; Bollschweiler E; Dittler HJ; Fink U; Hölscher AH; Roder JD
Chirurg; 1992 Sep; 63(9):693-700. PubMed ID: 1382922
[No Abstract] [Full Text] [Related]
16. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
18. [How safe is high intrathoracic esophagogastrostomy?].
Hölscher AH; Schröder W; Bollschweiler E; Beckurts KT; Schneider PM
Chirurg; 2003 Aug; 74(8):726-33. PubMed ID: 12928793
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant therapy in oesophageal cancer surgery].
Imdahl A
Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
[TBL] [Abstract][Full Text] [Related]
20. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
